Direct detection of rna mediated by reverse transcriptase lacking rnase h function
CA 2320102 A1 · Owner: De La Rosa, Abel · Inventors: Collier, Clayton D.; De La Rosa, Abel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is a method of detecting RNA molecules of interest in which reverse transcription primers unique to the RNA molecule of interest are used for reverse transcribing the RNA with a reverse transcriptase lacking RNAse H function and the resulting RNA/DNA hybrid is detected with an antibody specific for RNA/DNA hybrids. This method can be used to detect the presence of one or many specific RNA molecules which may be present in a sample including RNA from different organisms (such as viruses bacteria, fungi, plants, and animals), or RNA indicative of an infection a disease state, or , predisposition to a disease in an animal. The specificity of detection is increased relative to …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 3, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 3, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 3, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.